Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 2/2011

01-02-2011 | Research Articles

Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival

Authors: Sergej Osinsky, Larissa Bubnovskaya, Irina Ganusevich, Antonina Kovelskaya, Lilya Gumenyuk, Gennadij Olijnichenko, Sergej Merentsev

Published in: Clinical and Translational Oncology | Issue 2/2011

Login to get access
Metadata
Title
Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival
Authors
Sergej Osinsky
Larissa Bubnovskaya
Irina Ganusevich
Antonina Kovelskaya
Lilya Gumenyuk
Gennadij Olijnichenko
Sergej Merentsev
Publication date
01-02-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0630-0

Other articles of this Issue 2/2011

Clinical and Translational Oncology 2/2011 Go to the issue

Research Articles

Radiotherapy in rectal cancer: development, adequacy and radiotherapy utilisation rate. A comparative analysis with the most frequent tumour sites

Educational Series

Unknown primary cancer of the head and neck: a multidisciplinary approach

Educational Series

The role of iron in tumour cell proliferation

News and Views

Delaying oxidation

Educational Series

Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway

Research Articles

The role of plastic surgery in sarcoma treatment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits